Claire Bournaud
About
Claire Bournaud is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology.
According to data from OpenAlex, Claire Bournaud has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Claire Bournaud's work include Thyroid Cancer Diagnosis and Treatment (42 papers), Neuroendocrine Tumor Research Advances (13 papers) and Thyroid Disorders and Treatments (13 papers). Claire Bournaud is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (42 papers), Neuroendocrine Tumor Research Advances (13 papers) and Thyroid Disorders and Treatments (13 papers). Claire Bournaud collaborates with scholars based in France, United States and Switzerland. Claire Bournaud's co-authors include Françoise Borson‐Chazot, Jacques Orgiazzi, Sophie Leboulleux, Martin Schlumberger, Isabelle Borget, Bogdan Catargi, Slimane Zerdoud, Stéphane Bardet, Danielle Benisvy and Marie‐Elisabeth Toubert and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.
In The Last Decade
Claire Bournaud
55 papers receiving 2.0k citations
Hit Papers
Peers
Claire Bournaud
Catherine Dinauer United States
Claudia Ceccarelli Italy
Claire Schvartz France
P.N. Plowman United Kingdom
Daria Handkiewicz-Junak Poland
Carlotta Giani Italy
Anca M. Avram United States
Marco Capezzone Italy
Shane O. LeBeau United States
Pietro Iacconi Italy
Citations per year, relative to Claire Bournaud Claire Bournaud (= 1×)
peers
Catherine Dinauer
Countries citing papers authored by Claire Bournaud
Since
Specialization
Citations
This map shows the geographic impact of Claire Bournaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Bournaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Bournaud more than expected).
Fields of papers citing papers by Claire Bournaud
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Claire Bournaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Bournaud. The network helps show where Claire Bournaud may publish in the future.
Co-authorship network of co-authors of Claire Bournaud
This figure shows the co-authorship network connecting the top 25 collaborators of Claire Bournaud. A scholar is included among the top collaborators of Claire Bournaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Bournaud. Claire Bournaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Cattaneo, Marco, Lawrence Dierickx, Péter Igaz, et al.. (2021). Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients. Cancers. 13(24). 6290–6290.
2.
Deandreis, Désirèe, Aline Maillard, Slimane Zerdoud, et al.. (2021). RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(10). 3238–3249.
3.
Schlumberger, Martin, Sophie Leboulleux, Bogdan Catargi, et al.. (2018). Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial. The Lancet Diabetes & Endocrinology. 6(8). 618–626.
4.
Illouz, F., Dominique Luton, Michel Polak, Alix Besançon, & Claire Bournaud. (2018). Graves’ disease and pregnancy. Annales d Endocrinologie. 79(6). 636–646.
5.
Giraudet, Anne‐Laure, David Kryza, Françoise Borson‐Chazot, et al.. (2017). Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT. Nuclear Medicine Communications. 38(9). 771–779.
6.
Zerdoud, Slimane, Anne‐Laure Giraudet, Sophie Leboulleux, et al.. (2017). Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology, Pathology, Biology, Endocrine Surgery and Head and Neck Surgery. Annales d Endocrinologie. 78(3). 162–175.
7.
Bellis, Annamaria De, Bruno Pereira, Claire Bournaud, et al.. (2016). Time course of Graves’ orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer. Medicine. 95(48). e5474–e5474.
8.
Lamblin, G., et al.. (2016). Goitres ovariens bénins : à propos de 7 cas et analyse de la littérature. Gynécologie Obstétrique & Fertilité. 44(5). 263–268.
9.
Taïeb, David, Claire Bournaud, Marie‐Claude Eberlé, et al.. (2016). Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves' hyperthyroidism undergoing radioiodine therapy: a randomized controlled study. European Journal of Endocrinology. 174(4). 491–502.
10.
Bournaud, Claire & Véronique Raverot. (2015). Follow-up of differentiated thyroid carcinoma. Annales d Endocrinologie. 76(1). 1S27–1S33.
11.
Chikh, Karim, Nadine Bossard, Patricia Bretones, et al.. (2014). Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. European Journal of Endocrinology. 171(4). 451–460.
12.
Salaün, Pierre‐Yves, L. Campion, C. Ansquer, et al.. (2014). 18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 41(8). 1501–1510.
13.
Salaün, Pierre‐Yves, L. Campion, Claire Bournaud, et al.. (2012). Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement. Journal of Nuclear Medicine. 53(8). 1185–1192.
14.
Derbel, Olfa, Céline Ségura‐Ferlay, Jean‐Christophe Lifante, et al.. (2011). Results of combined treatment of anaplastic thyroid carcinoma (ATC). BMC Cancer. 11(1). 469–469.
15.
Bournaud, Claire, Anne Charrié, Cécile Nozières, et al.. (2010). Thyroglobulin measurement in fine-needle aspirates of lymph nodes in patients with differentiated thyroid cancer: a simple definition of the threshold value, with emphasis on potential pitfalls of the method. Clinical Chemistry and Laboratory Medicine (CCLM). 48(8). 1171–1177.
16.
Sassolas, Geneviève, Anne‐Marie Schott, Claire Bournaud, et al.. (2009). Geographical correlation between incidence of benign disease and that of cancer of the thyroid among the population of the Rhône-Alpes région of France. European Journal of Endocrinology. 162(1). 127–135.
17.
Borget, Isabelle, et al.. (2008). 131 I Effective Half-Life and Dosimetry in Thyroid Cancer Patients. Journal of Nuclear Medicine. 49(9). 1445–1450.
18.
Laurberg, Peter, Claire Bournaud, Jesper Karmisholt, & Jacques Orgiazzi. (2008). Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. European Journal of Endocrinology. 160(1). 1–8.
19.
Raverot, Gérald, Alain Calender, Jacqueline Trouillas, et al.. (2007). Familial pituitary adenomas with a heterogeneous functional pattern: Clinical and genetic features. Journal of Endocrinological Investigation. 30(9). 787–790.
20.
Giammarile, Francesco, Claire Bournaud, M. Janier, et al.. (2003). Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?. European Journal of Endocrinology. 149(4). 293–300.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Catherine Dinauer Breakdown of academic impact, for papers by Claudia Ceccarelli Breakdown of academic impact, for papers by Claire Schvartz Breakdown of academic impact, for papers by P.N. Plowman Breakdown of academic impact, for papers by Daria Handkiewicz-Junak Breakdown of academic impact, for papers by Carlotta Giani Breakdown of academic impact, for papers by Anca M. Avram Breakdown of academic impact, for papers by Marco Capezzone Breakdown of academic impact, for papers by Shane O. LeBeau Breakdown of academic impact, for papers by Pietro Iacconi